A Systematic Analysis of Host Factors Reveals a Med23-Interferon-lambda l Regulatory Axis against Herpes Simplex Virus Type 1 Replication

作者：Griffiths Samantha J^*; Koegl Manfred; Boutell Chris; Zenner Helen L; Crump Colin M; Pica Francesca; Gonzalez Orland; Friedel Caroline C; Barry Gerald; Martin Kim; Craigon Marie H; Chen Rui; Kaza Lakshmi N; Fossum Even; Fazakerley John K; Efstathiou Stacey; Volpi Antonio; Zimmer Ralf; Ghazal Peter; Haas Juergen

来源：PLoS Pathogens, 2013, 9(8): e1003514.

DOI：10.1371/journal.ppat.1003514

Herpes simplex virus type 1 (HSV-1) is a neurotropic virus causing vesicular oral or genital skin lesions, meningitis and other diseases particularly harmful in immunocompromised individuals. To comprehensively investigate the complex interaction between HSV-1 and its host we combined two genome-scale screens for host factors (HFs) involved in virus replication. A yeast two-hybrid screen for protein interactions and a RNA interference (RNAi) screen with a druggable genome small interfering RNA (siRNA) library confirmed existing and identified novel HFs which functionally influence HSV-1 infection. Bioinformatic analyses found the 358 HFs were enriched for several pathways and multi-protein complexes. Of particular interest was the identification of Med23 as a strongly anti-viral component of the largely pro-viral Mediator complex, which links specific transcription factors to RNA polymerase II. The anti-viral effect of Med23 on HSV-1 replication was confirmed in gain-of-function gene overexpression experiments, and this inhibitory effect was specific to HSV-1, as a range of other viruses including Vaccinia virus and Semliki Forest virus were unaffected by Med23 depletion. We found Med23 significantly upregulated expression of the type III interferon family (IFN-lambda) at the mRNA and protein level by directly interacting with the transcription factor IRF7. The synergistic effect of Med23 and IRF7 on IFN-lambda induction suggests this is the major transcription factor for IFN-lambda expression. Genotypic analysis of patients suffering recurrent orofacial HSV-1 outbreaks, previously shown to be deficient in IFN-lambda secretion, found a significant correlation with a single nucleotide polymorphism in the IFN-lambda 3 (IL28b) promoter strongly linked to Hepatitis C disease and treatment outcome. This paper describes a link between Med23 and IFN-lambda, provides evidence for the crucial role of IFN-lambda in HSV-1 immune control, and highlights the power of integrative genome-scale approaches to identify HFs critical for disease progression and outcome.

• 出版日期2013-8